Treatment and control of modifiable cardiovascular risk factors among patients with diabetes mellitus and hypertension in Inner Mongolia: A cross‐sectional study

Abstract

The authors assessed treatment and control of blood glucose, blood pressure (BP), and blood lipids among patients from Inner Mongolia with diabetes mellitus (DM) and hypertension (HTN) and identified the modifiable factors associated with treatment and achievement of blood glucose, BP, and blood lipid targets. The authors used a multistage stratified cluster sampling method according to geographical location and level of economic development in Inner Mongolia. Among patients with DM and HTN, the crude rates of fasting plasma glucose (FPG) treatment and control was 30.76% and 4.73%, respectively. Crude rates of BP treatment and control were 50.81% and 8.70%, respectively. The authors found that treatment rates of HTN and DM and control rates of BP and FPG showed a gradually increasing trend with increased age. Among patients with DM and HTN, the likelihood of treatment for HTN and DM was significantly increased among participants who were older, non-Mongolian, male, obese, smokers, and those with previous cardiovascular disease. The authors found that control of BP, FPG, and low-density lipoprotein cholesterol was far from optimal among study participants. Medical and health departments in Inner Mongolia should take appropriate measures to reduce the burden of DM and HTN in the population, such as by promoting and improving the quality of HTN and DM treatment to achieve control goals and reduce the risk of cardiovascular disease.

Trends and Comparisons of Blood Pressure and Fasting Plasma Glucose in Patients with Hypertension, Diabetes, and Comorbidity: 4-Year Follow-Up Data

“…So far, however, there has been little discussion about the FPG control rate in comorbid patients. Bi et al 44 found that 5.13% of hypertensive patients with diabetes achieved the FPG control goal in Inner Mongolia, which was much lower than the control rate in this study. This discrepancy could be attributed to the fact that the patients in this study had better adherence to medication and life interventions due to follow-up, the baseline FPG of the patients was lower in this study, the stricter FPG control goal of Bi’s study, and regional and demographic differences.…”

“…So far, however, there has been little discussion about the FPG control rate in comorbid patients. Bi et al 44 found that 5.13% of hypertensive patients with diabetes achieved the FPG control goal in Inner Mongolia, which was much lower than the control rate in this study. This…”